You are here

• Home
• Therapy Areas
• Respiratory/Inflammation

• A Phase 3, randomised, open-label, crossover study to compare HFA vs CFC pMDI formulations of budesonide on methacholine hyper-reactivity in patients with stable, persistent, mild to moderate asthma

Disease

asthma

Drug Name

Pulmicort

Generic Name

budesonide

Sponsor

AstraZeneca

Drug Status

Approved Medicine

Phase

III

Start Date

Apr 15, 2008

Study Name

D5252C00008

Study Id

D5252C00008

Recruiting Status

Open

Protocol Status

Not Available

Report

Oct 19, 2009

• D5252C00008.pdf (218 KB)

Page tools

• Print
• Bookmark this page